Posted: 12 November 2021
CUREator is a national biotechnology incubator run by the Brandon Capital’s Medical Research Commercialisation Fund (MRCF).
Aimed at supporting the development of Australian biomedical innovations, CUREator is a nationwide program offering grant funding for a select number of preclinical medical research and medical innovation projects, and clinical-stage novel therapeutics.
CUREator is now calling for Expressions of Interest (EOI) for its Preclinical Stream and Clinical Stream. Any Australian small to medium size enterprise (SME), or life science researcher at an Australian university or research institute, is eligible to apply for funding.
Do you require funding support to complete key proof-of-concept experiments, mechanism of action, lead optimisation and lead selection, formal developmental, indication selection and commercial positioning or validation activities? Or are you an Australian SME in early-stage clinical development for a novel therapeutic?
Join us to chat all things CUREator – the team will run you through the program, what we are looking for in Expressions of Interest, before rounding off the session with a 15 minute Q&A.